Francis Ndungu/Lancet Infect Dis
1 results
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.Huttner, A.
Agnandji, S. T.
Combescure, C.
Fernandes, J. F.
Bache, E. B.
Kabwende, L.
Ndungu, F. M.
Brosnahan, J.
Monath, T. P.
Lemaitre, B.
Grillet, S.
Botto, M.
Engler, O.
Portmann, J.
Siegrist, D.
Bejon, P.
Silvera, P.
Kremsner, P.
Siegrist, C. A.
Vebcon,
Vsv, Ebovac
Vsv-Eboplus Consortia
Lancet Infect Dis, (2018). 18:738-748